Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Jan 29;74(2):363.
doi: 10.1093/cid/ciab467.

Beware of Biases in Observational Studies on Anti-Spike Monoclonal Antibodies

Giuseppe Lapadula  1 , Davide Paolo Bernasconi  2 , Alessandro Soria  1 , Maria Grazia Valsecchi  2 , Paolo Bonfanti  1   3
Affiliations
Comment

Beware of Biases in Observational Studies on Anti-Spike Monoclonal Antibodies

Giuseppe Lapadula et al. Clin Infect Dis. .
No abstract available

PubMed Disclaimer

Comment in

  • Reply to Lapadula et al.
    Kumar RN, Wu EL, Stosor V, Moore WJ, Achenbach C, Ison MG, Angarone MP. Kumar RN, et al. Clin Infect Dis. 2022 Jan 29;74(2):363-364. doi: 10.1093/cid/ciab468. Clin Infect Dis. 2022. PMID: 34015090 Free PMC article. No abstract available.

Comment on

References

    1. Kumar R, Wu E, Stosor E, et al. Real-world experience of bamlanivimab for COVID-19: a case-control study. Clin Infect Dis 2022; 74:24–31. - PMC - PubMed
    1. Chen P, Nirula A, Heller B, et al. ; BLAZE-1 Investigators . SARS-CoV-2 neutralizing antibody LY-CoV555 in outpatients with Covid-19. N Engl J Med 2021; 384:229–37. - PMC - PubMed
    1. Gottlieb RL, Nirula A, Chen P, et al. Effect of bamlanivimab as monotherapy or in combination with etesevimab on viral load in patients with mild to moderate COVID-19: a randomized clinical trial. JAMA 2021; 325:632–44. - PMC - PubMed
    1. Weinreich DM, Sivapalasingam S, Norton T, et al. ; Trial Investigators . REGN-COV2, a neutralizing antibody cocktail, in outpatients with Covid-19. N Engl J Med 2021; 384:238–51. - PMC - PubMed
    1. Suissa S. Immortal time bias in observational studies of drug effects. Pharmacoepidemiol Drug Saf 2007; 16:241–9. - PubMed

MeSH terms

Substances